Antonini A - Search Results

1

Parkinson disease: Can dopamine transporter imaging define early PD?

Antonini A, Biundo R. Antonini A, et al. Nat Rev Neurol. 2014 Aug;10(8):432-3. doi: 10.1038/nrneurol.2014.123. Epub 2014 Jul 8. Nat Rev Neurol. 2014. PMID: 25002108 No abstract available.

2

Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.

Ruggieri S, Carta A, Stocchi F, Antonini A, Bellantuono P, Monge A. Ruggieri S, et al. Among authors: antonini a. Funct Neurol. 1988 Oct-Dec;3(4):471-9. Funct Neurol. 1988. PMID: 3072281 Review. No abstract available.

3

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.

Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL. Antonini A, et al. Neurology. 1994 Jul;44(7):1325-9. doi: 10.1212/wnl.44.7.1325. Neurology. 1994. PMID: 8035939

4

Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.

Schwarz J, Antonini A, Kraft E, Tatsch K, Vogl T, Kirsch CM, Leenders KL, Oertel WH. Schwarz J, et al. Among authors: antonini a. Neurology. 1994 Jun;44(6):1079-82. doi: 10.1212/wnl.44.6.1079. Neurology. 1994. PMID: 8208404

5

T2 relaxation time in patients with Parkinson's disease.

Antonini A, Leenders KL, Meier D, Oertel WH, Boesiger P, Anliker M. Antonini A, et al. Neurology. 1993 Apr;43(4):697-700. doi: 10.1212/wnl.43.4.697. Neurology. 1993. PMID: 8469325

6

[11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length.

Antonini A, Leenders KL, Eidelberg D. Antonini A, et al. Ann Neurol. 1998 Feb;43(2):253-5. doi: 10.1002/ana.410430216. Ann Neurol. 1998. PMID: 9485067 Clinical Trial.

7

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

Antonini A, Kazumata K, Feigin A, Mandel F, Dhawan V, Margouleff C, Eidelberg D. Antonini A, et al. Mov Disord. 1998 Mar;13(2):268-74. doi: 10.1002/mds.870130212. Mov Disord. 1998. PMID: 9539340

8

Dopamine transporter imaging with fluorine-18-FPCIT and PET.

Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, Neumeyer J, Eidelberg D. Kazumata K, et al. Among authors: antonini a. J Nucl Med. 1998 Sep;39(9):1521-30. J Nucl Med. 1998. PMID: 9744335 Free article.

9

The metabolic anatomy of tremor in Parkinson's disease.

Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. Antonini A, et al. Neurology. 1998 Sep;51(3):803-10. doi: 10.1212/wnl.51.3.803. Neurology. 1998. PMID: 9748030

10

Hydrocarbon exposure and Parkinson's disease.

Pezzoli G, Canesi M, Antonini A, Righini A, Perbellini L, Barichella M, Mariani CB, Tenconi F, Tesei S, Zecchinelli A, Leenders KL. Pezzoli G, et al. Among authors: antonini a. Neurology. 2000 Sep 12;55(5):667-73. doi: 10.1212/wnl.55.5.667. Neurology. 2000. PMID: 10980731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results